Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 31.32

+1.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gerald Thomas who wrote (147)	4/25/1997 7:00:00 AM
From: Douglas	of 455

The Cameroon results would give you that impression. I went back to the press release, it said that COB and UNAIDS initiated their international Phase III clinical study in May of 1996. This was before the results of the Cameroon study were published. In July of 1996 COB announced the commencement of Phase I/II clinical trials at Roger Williams Medical Center in Providence, RI, for its novel HIV/AIDS therapy SPC3. No results published yet.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next